Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05374187 · ClinicalTrials.gov registry record · NA

Efficacy of Trigeminal Nerve Stimulation for ADHD

A NA study of Attention Deficit Hyperactivity Disorder, sponsored by University of California, Los Angeles.

Recruiting
Registry status
NA
Development phase
280
Enrollment target
2
Study locations

NCT05374187 is a NA study of Attention Deficit Hyperactivity Disorder that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 280 participants, above the 204-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (37% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05374187, a NA study of Attention Deficit Hyperactivity Disorder, is actively recruiting participants, sponsored by University of California, Los Angeles.

RECRUITING
Registry status
NA
Development phase
280 participants
Enrollment target
2
Study locations

Study Summary

This study is a large multisite randomized clinical trial to asses the efficacy of external trigeminal nerve stimulation (TNS), a novel, minimal risk, non-invasive neuromodulation treatment, for ADHD in children ages 7-12 years old (N=180). Study hypotheses address potential differences in ADHD symptoms over 4 weeks treatment with active vs. sham TNS in an expanded multi-site investigation; whether resting state fronto-parietal connectivity mediates TNS impact on ADHD symptoms; if changes in fronto-parietal activation, as measured by electroencephalography (EEG), predict TNS-related treatment outcomes; and whether a baseline cognitive profile similarly predicts response to TNS therapy.

Conditions Studied

Attention Deficit Hyperactivity Disorder

Interventions

  • DEVICE Active eTNS
  • DEVICE Sham eTNS

Study Locations (2)

California

  • University of California, Los Angeles - Los Angeles

Washington

  • Seattle Children's Hospital - Seattle

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2022-09-01
Est. Completion 2026-01-31
Phase NA

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05374187

The ClinicalTrials.gov registry entry for NCT05374187 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 204-participant average among 88 other Attention Deficit Hyperactivity Disorder trials with a reported enrollment target (37% higher). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Attention Deficit Hyperactivity Disorder appearing as the primary indexed condition, and to 2 interventions - of which Active eTNS is the first listed.

NCT05374187 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Washington.

Frequently Asked Questions

What is clinical trial NCT05374187 about?

NCT05374187 is a clinical study titled "Efficacy of Trigeminal Nerve Stimulation for ADHD". This study is a large multisite randomized clinical trial to asses the efficacy of external trigeminal nerve stimulation (TNS), a novel, minimal risk, non-invasive neuromodulation treatment, for ADHD in children ages 7-12 years old (N=180). Study hypotheses address potential differences in ADHD sym...

What is the current status of trial NCT05374187?

This trial is currently recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2022-09-01. Estimated completion is 2026-01-31.

What conditions does trial NCT05374187 study?

This clinical trial studies the following conditions: Attention Deficit Hyperactivity Disorder.

What interventions are being tested in trial NCT05374187?

The interventions under investigation include: Active eTNS (DEVICE), Sham eTNS (DEVICE).

Who is sponsoring clinical trial NCT05374187?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05374187 being conducted?

This trial has 2 study locations across California, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Attention Deficit Hyperactivity Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Attention Deficit Hyperactivity Disorder

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.